- Home
- MSGM vs APVO Comparison
MSGM vs APVO Comparison
Compare MSGM & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGM
- APVO
- Stock Information
- Founded
- MSGM 2018
- APVO 2016
- Country
- MSGM United States
- APVO United States
- Employees
- MSGM N/A
- APVO N/A
- Industry
- MSGM Computer Software: Prepackaged Software
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- MSGM Technology
- APVO Health Care
- Exchange
- MSGM Nasdaq
- APVO Nasdaq
- Market Cap
- MSGM 4.9M
- APVO 5.4M
- IPO Year
- MSGM 2021
- APVO N/A
- Fundamental
- Price
- MSGM $1.26
- APVO $3.47
- Analyst Decision
- MSGM Hold
- APVO Strong Buy
- Analyst Count
- MSGM 1
- APVO 1
- Target Price
- MSGM $5.00
- APVO $296.00
- AVG Volume (30 Days)
- MSGM 35.0K
- APVO 44.0K
- Earning Date
- MSGM 03-31-2025
- APVO 03-04-2025
- Dividend Yield
- MSGM N/A
- APVO N/A
- EPS Growth
- MSGM N/A
- APVO N/A
- EPS
- MSGM 1.84
- APVO N/A
- Revenue
- MSGM $8,460,953.00
- APVO N/A
- Revenue This Year
- MSGM $23.00
- APVO N/A
- Revenue Next Year
- MSGM $72.82
- APVO N/A
- P/E Ratio
- MSGM $0.68
- APVO N/A
- Revenue Growth
- MSGM N/A
- APVO N/A
- 52 Week Low
- MSGM $1.01
- APVO $3.01
- 52 Week High
- MSGM $4.16
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- MSGM 41.47
- APVO 33.42
- Support Level
- MSGM $1.25
- APVO $3.20
- Resistance Level
- MSGM $1.33
- APVO $3.65
- Average True Range (ATR)
- MSGM 0.07
- APVO 0.34
- MACD
- MSGM -0.01
- APVO 0.01
- Stochastic Oscillator
- MSGM 5.26
- APVO 31.51
About MSGM Motorsport Games Inc.
Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.